Abstract

Particle Size Distribution of Propofol Injection from Ampules and Vials: The Benefits of Filitration

Author(s): Driscoll David F, Deaconess Beth Israel, Lawrence Kenneth R, Lewis Keith, Bistrian Bruce R

Issue: Mar/Apr 1997 - Pediatric Care

Page(s): 118-120

Download in electronic PDF format for $75
  • Particle Size Distribution of Propofol Injection from Ampules and Vials: The Benefits of Filitration Page 1
  • Particle Size Distribution of Propofol Injection from Ampules and Vials: The Benefits of Filitration Page 2
  • Particle Size Distribution of Propofol Injection from Ampules and Vials: The Benefits of Filitration Page 3

Abstract

The Centers for Disease Control has identified intravenous propofol, a lipid-based medication, as a cause of postoperative infections in hospitalized patients. It appears the increased risk results from poor aseptic technique in the preparation, storage and administration of extemporaneously prepared propofol infusions. An additional risk of preparing propofol injection includes glass particulate contamination when the ampule dosage form is used. The current study, therefore, examines the extrinsic particulate load between propofol syringes prepared from ampules and vials with and without the use of a filter needle.

Ten operating room clinicians were asked to prepare propofol infusion from ampules using a standard needle and a special filter needle. A similar comparison was performed separately in the laboratory using propofol vials to deduce differences between the normal presence of fat globules and the adventitious introduction of glass particulates from propofol ampules. Particle size analysis was determined by a single-particle, opticalsensing device using laser light extinction. Aliquots of the unfiltered and filtered samples were analyzed in triplicate by number-weighting all particles = 1.75 µm (instrument threshold for detecting abnormal particles) and all particles > 5 µm and > 10 µm (theoretical physiologic threshold for producing embolic syndrome). Significant differences were noted between dosage forms with respect to the number of particulates present from the pre- to the postfiltrate samples.

A reduction in very large particulates (> 10 µm) was observed from the ampules (p=0.034). No differences were noted for the smaller particles (> 1.75 µm, p=0.333; > 5 µm, p=0.229). Of the propofol vial samples, no differences were noted for the larger particles (> 5 µm, p=0.575; > 10 µm, p=0.229). However, a significant increase in particle size was noted for the smallest particles (> 1.75 µm, p=0.0001). This increase in the number of particles in the postfiltrate may reflect the effects of filtration in destabilizing lipid particles.

The use of the 5-µm filter needle significantly reduced the amount of abnormally large particles (> 10 µm) from the ampule dosage form, whereas no difference was observed from the propofol vials. This implies the abnormal particles present were other than lipid and likely to be glass associated with ampule breakage, suggesting the 5-µm filter needle be a standard part of propofol therapy when preparing infusions from ampule dosage forms.

Related Keywords

Related Categories

Printer-Friendly Version

Related Articles from IJPC

Issue/Page
View/Buy
Title/Author
(Click for Abstract / Details / Purchase)
Mar/Apr 1997
Pg. 118-120
View Sample
Jan/Feb 2009
Pg. 78-80
Jul/Aug 2016
Pg. 283-292
Mar/Apr 1997
Pg. 132-134
Jul/Aug 2014
Pg. 270-276
Nov/Dec 2015
Pg. 491-500
Author(s): Akers Michael J
Jul/Aug 2013
Pg. 270-280
Jul/Aug 2021
Pg. 298-302
Jan/Feb 2017
Pg. 47-56
Author(s): Akers Michael J
Sep/Oct 2020
Pg. 434-438
Sep/Oct 2003
Pg. 364-365
Author(s): Allen Loyd V Jr
May/Jun 2004
Pg. 228-230
Mar/Apr 2013
Pg. 100-110
Jan/Feb 2018
Pg. 41-46
Jan/Feb 2014
Pg. 87
Author(s): Lees Deril J
May/Jun 2019
Pg. 221-228
Author(s): Allen Loyd V Jr
May/Jun 2011
Pg. 224-232
Jul/Aug 1999
Pg. 260-261
Author(s): Karolchyk Scott
Jan/Feb 2000
Pg. 66-68
Nov/Dec 2007
Pg. 502-503
Author(s): Allen Loyd V Jr